Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7333 p85
22 January 2005

This article
Reprint   Photocopy

PDF 100K, Acrobat Reader

Letters

· The Society (23)
· Overseas pharmacists (2)
· Fellowship (2)
· Diamorphine
· Morphine sulphate
· Chloramphenicol
· Drug donations
· The Journal (2)


Letters to the Editor

Fellowship

Can the Byelaws be changed? (Miss J Greenleaf)

Callous disregard of distinguished people (Mrs A Farrelly)

Can the Byelaws be changed?

From Miss J. Greenleaf, FRPharmS

As a past member of the Panel of Fellows, I am horrified at the prospect that those whom the Royal Pharmaceutical Society has designated fellows for distinction in their contribution to pharmacy over many years should be stripped of that honour, not because they have done something disgraceful but because they now feel obliged to resign from the Register for whatever reason, such as that they feel unable to pay the proposed greatly increased fees or sign the non-practising statement in its present form (PJ, 15 January, p49).

I am aware that the Byelaws require that Fellows should be on the Register but surely some serious thought should be given to ways of continuing to honour these people. Can the Byelaws be changed? If not, could not these people simply be redesignated as honorary fellows?

Joan Greenleaf
Croydon, Surrey


Callous disregard of distinguished people

From Mrs A. Farrelly, MRPharmS

I am ashamed that the Royal Pharmaceutical Society, designated a “caring profession”, should give such a bad example in caring for its members. Surely the reply from the Secretary and Registrar to the fellows (PJ, 15 January, p49) should at least have indicated a willingness to offer a title such as “FRPharmS Rtd”. If this requires a change in the Byelaws then let the change be made.

Such callous disregard of distinguished people gives an uninviting prospect for new pharmacists: “Devote your life to us and we will kick you in the teeth.”

Ann Farrelly
Wallington, Surrey

Send your letter to The Editor

Previous Topic (Overseas pharmacists)
Next Topic (Diamorphine)

Back to Top


©The Pharmaceutical Journal